Scarica l'app Stockscreener
0.6404
0.73%
-0.0047
Pre-mercato:
.62
-0.0204
-3.19%
Nexentis Technologies Inc Borsa (NXTS) Ultime notizie
NXTS Stock Slides As Charts And Cash Flow Flash Caution - Timothy Sykes
NXTS Stock Compresses As Traders Study Key Levels - StocksToTrade
NXTS Stock Tests Volatility As Cash Cushion Buys Time - StocksToTrade
Nexentis Amends All Outstanding Warrants to Equity Classification for Nasdaq Compliance - Minichart
Warrant amendments at Nexentis (NXTS) add no shares upon exercise and do not extend their terms. - Stock Titan
NXTS Forecast — Price Target — Prediction for 2027 - TradingView
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board - GlobeNewswire Inc.
Nexentis Technologies Inc. (NXTS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Nexentis Technologies Inc. (NXTS) stock price, news, quote and history - Yahoo Finance UK
Nexentis Technologies Faces Nasdaq Compliance and Delisting Risk - The Globe and Mail
Nexentis Faces Nasdaq Delisting Over Equity Shortfall - minichart.com.sg
Nexentis Technologies Faces Nasdaq Compliance and Delisting Risk - TipRanks
Nexentis Technologies Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView
NXTS - Finviz
Nexentis Technologies Inc. (NASDAQ: NXTS) Share Price, NXTS Stock News, NXTS Share Price & Updates - Kalkine
Nexentis Technologies Inc. (NXTS) Rises 5.98% to $1.95, Approaching Key Resistance at $2.05Hedge Fund Favorites - Vinanet
Nexentis Technologies (NXTS) flags going concern after $17.7M loss and $6.3M impairment - Stock Titan
Nexentis Technologies Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nexentis Technologies Inc. (NXTS) Rises 5.98% to $1.95, Approaching Key Resistance at $2.05Hedge Fund Favorites - vinanet.vn
Nexentis Technologies (NASDAQ: NXTS) changes auditors after prior going concern note - Stock Titan
Nexentis Technologies (NXTS) Gains 4% as Bullish Momentum Builds Toward Key $2.03 ResistanceInstitutional Volume - vinanet.vn
NXTS Q2 2025 Earnings: Loss of $0.18 Per Share Reported as Stock Climbs 10.32%Analyst Earnings Estimate - vinanet.vn
NXTS Q2 2025 Earnings: Reported Loss of -$0.18 Per Share, Yet Shares Jump 10.32%Financial Health Score - vinanet.vn
Nexentis subsidiary selects candidate for drug discovery program By Investing.com - Investing.com Canada
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - globenewswire.com
Nexentis Technologies Subsidiary MitoCareX Bio Selects Transport Protein Candidate for Drug Discovery Campaign - The Manila Times
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing ChallengesDividend Cut Risk - dars.gov.et
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing Challenges - dars.gov.et
Nexentis Technologies Inc. (NXTS) Q2 2025 Earnings: Loss and Stock Decline Reflect Ongoing Challenges - dars.gov.et
Nexentis Technologies Inc. Revenue Breakdown – NASDAQ:NXTS - TradingView
Nexentis Technologies (NXTS) Drops 7%: Key Support Level in FocusStraddle Setup - dars.gov.et
NXTS Q2 2025 Earnings: Wider-than-expected loss drives shares down 7.86%Earnings Season Outlook - vinanet.vn
Nexentis Technologies Inc. SEC Filing (Jul 20, 2026) - Stock Titan
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffAnalyst Drop Coverage - dars.gov.et
NXTS Q2 2025 Earnings: Reported Loss of $0.18 per Share Amid Market SelloffDownward Estimate Revision - vinanet.vn
Nexentis Technologies soars 156% before falling 46% after hours — here’s why NXTS stock is trending - MSN
Nexentis Technologies Inc. SEC Filing (Jul 16, 2026) - Stock Titan
Eun Young Lee holds 3.23% of Nexentis Technologies Inc. (NXTS) - Stock Titan
NXTS Q2 2025 Earnings: Wider-Than-Expected Loss Sends Shares LowerMargin Compression Risk - vinanet.vn
Nexentis Technologies files prospectus for 2.573M shares - scanx.trade
Nexentis Technologies registers to sell 2.57M shares of common stock for holders - TipRanks
Nexentis Technologies (NASDAQ: NXTS) refreshes $100M shelf and details MitoCareX deal - Stock Titan
Nexentis Technologies (NASDAQ: NXTS) registers 2.57M warrant shares for resale - Stock Titan
Nexentis Technologies Q2 2025 Earnings: Loss of -$0.18 Per Share Sends Stock Down 14.56%Earnings Power Value - vinanet.vn
Nexentis Technologies (NXTS) Slides 4.5% as Selling Pressure Tests Key Support at $3.46Double EMA - dars.gov.et
NXTS Q2 2025 Earnings: Net Loss of $0.18 Per Share as Stock Slips 3.6%Earnings Quality Score - dars.gov.et
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - The Manila Times
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter - GlobeNewswire
Nexentis Subsidiary MitoCareX Bio Advances SLC Transporter Drug Discovery with Broad Analysis and International AI Initiative - Barchart.com
NXTSNexentis Technologies Inc Earnings - Finviz
1.06%
0.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):